Related Experiment Video
Updated: Jun 3, 2026
04:53
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Designing clinical trials in older people.
1Peninsula College of Medicine and Dentistry, University of Plymouth, Dept. Clinical Neurobiology, John Bull Building, Tamar Science Park, Research Way, Plymouth, Devon, UK. camille.carroll@pms.ac.uk
Maturitas
|March 8, 2011
Summary
Older adults are under-represented in clinical trials, limiting crucial data for their medical care. Addressing recruitment and design challenges is vital for inclusive research in the ageing population.
Area of Science:
- Gerontology
- Clinical Trials
- Medical Research
Background:
- The ageing population requires specific clinical trial data for effective medical care and disease understanding.
- Older adults are significantly under-represented in clinical trials, leading to a lack of evidence-based treatments.
- Existing clinical trial designs often exclude elderly individuals due to eligibility criteria and physician perceptions.
Purpose of the Study:
- To review the challenges in conducting clinical trials with older populations.
- To highlight the need for robust clinical trial data in geriatric medicine.
- To discuss initiatives for improving the inclusion of elderly participants in research.
Main Methods:
- This is a review article.
- It synthesizes existing literature on the challenges and solutions for clinical trials in older adults.
- It outlines difficulties in recruitment, retention, and data analysis.
Main Results:
- Under-representation of older adults in clinical trials is a well-documented issue.
- Key barriers include physician perceptions, strict eligibility criteria, and functional status requirements.
- Current trial designs are often not standardized for elderly participants with comorbidities.
Conclusions:
- Clinical trials for older people present unique challenges in design, recruitment, and retention.
- Standardized methodologies and adequate resources are essential for successful trials in this demographic.
- Addressing these challenges is crucial to meet the therapeutic needs of an ageing population.
More Related Videos
Related Concept Videos
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...